Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML.
Kelvin JM, Jain J, Thapa A, Qui M, Birnbaum LA, Moore SG, Zecca H, Summers RJ, Costanza E, Uricoli B, Wang X, Jui NT, Fu H, Du Y, DeRyckere D, Graham DK, Dreaden EC.
Kelvin JM, et al. Among authors: fu h.
bioRxiv [Preprint]. 2023 Mar 15:2023.03.13.531236. doi: 10.1101/2023.03.13.531236.
bioRxiv. 2023.
PMID: 36993676
Free PMC article.
Updated.
Preprint.